Invasive Lobular Carcinoma (ILC)

Invasive Lobular Carcinoma (ILC) is the second most common type of breast cancer, accounting for about 10-15% of all breast cancer cases. ILC begins in the lobules, the glands that produce milk, and can spread to other parts of the body. Due to its subtle nature, ILC can be harder to detect in its early stages. At Emirates Hospitals, we offer comprehensive care for patients diagnosed with ILC, using advanced diagnostic techniques and personalized treatment plans to ensure the best outcomes.

Symptoms of Invasive Lobular Carcinoma (ILC)

ILC can be more challenging to detect than other types of breast cancer because it often doesn’t cause a distinct lump. Common symptoms may include:

• Thickening or fullness in the breast.
• Changes in breast texture or appearance.
• Nipple inversion or skin changes.
• A general feeling of discomfort or tenderness in the breast.

If you notice any changes in your breast, it’s important to seek medical evaluation immediately for proper diagnosis.

Diagnostic Approach for Invasive Lobular Carcinoma

Early detection is critical for effective treatment of ILC. At Emirates Hospitals, we use state-of-the-art diagnostic tools to accurately diagnose ILC, including:

1. Mammography and Ultrasound: Imaging technologies used to detect abnormal changes in the breast.
2. Magnetic Resonance Imaging (MRI): Often used in cases of ILC to provide a clearer view of the breast tissue.
3. Biopsy: A sample of the affected tissue is taken for microscopic examination to confirm the presence of cancer cells.

These advanced diagnostic methods allow us to understand the extent and characteristics of the cancer, helping us create a personalized treatment plan.

Treatment Options for Invasive Lobular Carcinoma

ILC treatment depends on the size and stage of the cancer as well as the patient’s overall health. Emirates Hospitals provides a range of treatment options, including:

• Surgery: Either a lumpectomy (removal of the tumor) or mastectomy (removal of the breast) depending on the tumor size and spread.
• Radiation Therapy: Often used after surgery to target any remaining cancer cells in the breast.
• Chemotherapy: Administered before or after surgery to reduce the risk of recurrence.
• Hormonal Therapy: Effective for hormone receptor-positive ILC, reducing estrogen levels to prevent cancer growth.
• Targeted Therapy: Used for specific cases to target and destroy cancer cells with fewer side effects.